Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.

@article{Ullmann2003ReviewOT,
  title={Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole.},
  author={Andrew J Ullmann},
  journal={Current medical research and opinion},
  year={2003},
  volume={19 4},
  pages={263-71}
}
Managing invasive fungal infections often presents a challenge for clinicians in the treatment of immunocompromised patients. Two very different systemic antifungal agents, voriconazole and caspofungin, have recently been introduced into the market place. Voriconazole is a new triazole antifungal, while caspofungin is the first echinocandin antifungal. Voriconazole acts by inhibiting the synthesis of ergosterol in the fungal cell membrane. Caspofungin inhibits beta-1,3-D-glucan synthesis in the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

Similar Papers

Loading similar papers…